These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1597850)

  • 21. [A case of urinary retention caused by true phimosis].
    Minagawa T; Murata Y
    Hinyokika Kiyo; 2008 Jun; 54(6):427-9. PubMed ID: 18634440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorder of urine outflow from the kidney and arterial hypertension].
    Khirmanov VN; Tkachuk EV
    Urol Nefrol (Mosk); 1981; (1):61-5. PubMed ID: 7010751
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arterial hypertension with secondary hyperaldosteronism, reversible by nifedipine, in systemic scleroderma].
    Gouet D; Rouffineau J; Marechaud R; Thomas P; Pourrat O; Alcalay M; Bontoux D
    Ann Med Interne (Paris); 1983; 134(8):736-8. PubMed ID: 6666913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phimosis as a presenting feature of diabetes.
    Bromage SJ; Crump A; Pearce I
    BJU Int; 2008 Feb; 101(3):338-40. PubMed ID: 18005214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
    Kraft K; Schiessl S; Vetter H
    Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
    Soucek M; Prásek J; Spinarová L
    Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An atenolol/nifedipine tablet for hypertension--useful or not?
    Drug Ther Bull; 1989 Jun; 27(12):47-8. PubMed ID: 2519121
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy.
    Ural E; Kozdag G; Kilic T; Ural D; Sahin T; Celebi O; Komsuoglu B
    J Hum Hypertens; 2008 Mar; 22(3):208-10. PubMed ID: 17928875
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hypertensive coronary patients. Open long-term study with a combination of atenolol and nifedipine].
    Lindner UK
    Fortschr Med; 1991 Aug; 109(23):467-70. PubMed ID: 1916582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of nifedipine and its relationship to severity of hypertension.
    Yoshimura M; Takashina R; Shikuma R; Takahashi H; Takeda K; Ashizawa H; Ochi Y; Ijichi H
    Arzneimittelforschung; 1983; 33(2):254-7. PubMed ID: 6682666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of atenolol in moderate arterial hypertension. Evaluation by stress test].
    Arrieta JA; Alegría E; Huguet R; Larraz MP; Calabuig J; Martínez Caro D
    Rev Med Univ Navarra; 1987; 31(1):23-8. PubMed ID: 3616360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension.
    Edwards KG; Tweed JA; Saul PA; Wright FW
    Pharmatherapeutica; 1986; 4(10):637-41. PubMed ID: 3602015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of dynamic exercise on the blood pressure of patients with hypertension treated with atenolol and enalapril].
    Echeverriá RF; Camacho RO; Carbajal HA; Mileo HN; Salazar MR; Riondet B; Rodrigo C
    Medicina (B Aires); 1988; 48(3):234-8. PubMed ID: 2854605
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.